MULINACCI, BARBARA
 Distribuzione geografica
Continente #
NA - Nord America 1.132
EU - Europa 853
AS - Asia 240
OC - Oceania 15
AF - Africa 13
Totale 2.253
Nazione #
US - Stati Uniti d'America 1.131
RU - Federazione Russa 310
PL - Polonia 134
SE - Svezia 117
IE - Irlanda 91
SG - Singapore 79
IT - Italia 78
HK - Hong Kong 66
CN - Cina 51
FI - Finlandia 31
UA - Ucraina 30
CH - Svizzera 24
DE - Germania 23
JO - Giordania 17
AU - Australia 15
KR - Corea 13
CI - Costa d'Avorio 12
GB - Regno Unito 9
IN - India 5
TR - Turchia 5
FR - Francia 3
BE - Belgio 2
VN - Vietnam 2
CA - Canada 1
ID - Indonesia 1
JP - Giappone 1
NL - Olanda 1
SC - Seychelles 1
Totale 2.253
Città #
Santa Clara 425
Warsaw 134
Chandler 102
Dublin 91
Singapore 63
Fairfield 57
Hong Kong 44
Jacksonville 44
Ashburn 32
Woodbridge 32
Seattle 30
Lawrence 28
Altamura 27
Houston 27
Bern 24
Cambridge 24
Wilmington 24
Princeton 22
Boston 20
Ann Arbor 18
Beijing 18
Buffalo 18
Melbourne 15
Seoul 13
Abidjan 12
Florence 10
Kent 10
Helsinki 9
Shanghai 9
Boardman 8
Falls Church 8
Ravenna 5
Izmir 4
Mumbai 4
Norwalk 4
Padova 4
Andover 3
Medford 3
Mugnano di Napoli 3
Sala 3
San Diego 3
San Giorgio 3
Brussels 2
Dong Ket 2
Falkenstein 2
Frankfurt Am Main 2
Los Angeles 2
Melegnano 2
New York 2
Palermo 2
Redwood City 2
Venezia 2
Washington 2
West Jordan 2
Auburn Hills 1
Central 1
Chicago 1
Chioggia 1
Dearborn 1
Hanover 1
Hillsboro 1
Jakarta 1
Lappeenranta 1
Michendorf 1
Milan 1
Mont-saint-aignan 1
Napoli 1
Nuremberg 1
Phoenix 1
Quiliano 1
Rome 1
Shenyang 1
Tappahannock 1
Toronto 1
Turin 1
Verona 1
Yubileyny 1
Totale 1.484
Nome #
An N-glucosylated peptide detecting disease-specific autoantibodies, biomarkers of multiple sclerosis. 283
Assessment of new 6Cl-HOBt based coupling reagents for peptide synthesis. Part 1: Coupling efficiency study 127
CROSS-REACTIVITY STUDIES OF RMOGED WITH SYNTHETIC PUTATIVE AUTOANTIGENS CSF114(GLC) AND [N31(GLC)]HMOG(30-50)IN MULTIPLE SCLEROSIS PATIENTS'SERA 124
CONFORMATION-ACTIVITY RELATIONSHIP OF DESIGNED GLYCOPEPTIDES AS SYNTHETIC PROBES FOR THE DETECTION OF AUTOANTIBODIES, BIOMARKERS OF MULTIPLE SCLEROSIS 122
Identification of new autoantigens in Multiple Sclerosis by glycopeptide libraries 115
Small Focused Library of CSF114-type Glycopeptides For the Characterization of Autoantibody Recognition in Multiple Sclerosis 115
Cross-reactivity studies of rMOG(ED) with synthetic putative autoantigens CSF114(Glc) and [N-31(Glc)]hMOG(30-50) in multiple sclerosis patients' sera. 110
Beta-hairpin glycopeptides as mimetic autoantigens in Multiple Sclerosis 97
Structure-Activity Relationship Study of Glycopeptide Antigens Recognizing Specific Autoantibodies in Multiple Sclerosis 97
Beta-Hairpin glycopeptides as mimetic autoantigens in multiple sclerosis 91
MS PepKit: The first diagnostic test to follow-up multiple sclerosis 91
Improvement of autoantibody detection in autoimmune diseases by innovative solid-phase glycopeptide based technologies. 90
Identification of new autoantigens in Multiple Sclerosis by glycopeptide libraries 90
MS PepKit: the first diagnostic test based on CSF114(Glc), a glycopeptide to follow-up Multiple Sclerosis. 90
Sugar–Scan of CSF114(Glc) for autoantibody recognition in autoimmune diseases. 85
Antigenic probes for autoantibody detection in Multiple Sclerosis: synthetic peptides versus recombinant proteins 84
Semi-synthesis of glucosylated recombinant MOG as auto-antigen in multiple sclerosis. 84
Antigenic Probes for Autoantibody Detection in Multiple Sclerosis: Synthetic Peptides Versus Recombinant Proteins 84
A proteomic approach to characterize a native antigen involved in autoantibody response in Multiple Sclerosis by a structure-based designed glycopeptide. 83
Structure-activity relationship study of glycopeptide antigens recognizing specific autoantibodies in Multiple Sclerosis. 81
A Glycopeptide-based Technique for Selective Antibodies Purification. 80
MS PepKit, the first diagnostic test based on CSF114(Glc) a glycopeptide to follow-up Multiple Sclerosis. 75
Totale 2.298
Categoria #
all - tutte 6.326
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 6.326


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/202083 0 0 0 0 0 0 16 23 12 13 16 3
2020/2021158 13 7 17 11 2 30 4 14 12 27 10 11
2021/2022120 4 18 2 5 4 5 5 5 1 6 29 36
2022/2023446 30 87 35 22 24 85 58 16 53 3 6 27
2023/2024175 10 16 24 12 4 10 20 42 0 3 26 8
2024/2025938 45 112 70 191 316 202 2 0 0 0 0 0
Totale 2.298